Jens Mogensen 🔸

Fairlo is on a mission to level the playing field and outsmart the predatory credit market by creating fair financial services from scratch. Since launch, our customers solve short- to medium term borrowing needs in real-time. With the aid of technology, weve created automated, easy-to-use services based on transparency and fairness. We pair our cutting-edge tech with unprecedented terms. Fair terms that continually beat traditional banks, popular credit cards and checkout solutions alike. Were backed by one of the Nordics most well-known incubators – Sting, Stockholm Innovation & Growth AB – as well as Swedish state-owned Saminvest and a multitude of experienced investors. Were an international company with roots in the Swedish capital of Stockholm. Follow us on LinkedIn to get the latest on investing rounds, hiring, tech development, press, and thought leadership.

Beactica Therapeutics is a specialist drug discovery and development company, committed to the fight against cancer. Beactica is advancing a proprietary pipeline of first-in-class therapeutics by applying its molecular interaction-based drug discovery engine synergistically across multiple small molecule modalities – including allosteric modulators, protein–protein interaction inhibitors and targeted protein degraders (PROTACs).

1928 Diagnostics offers a bioinformatics analytics platform for infection control. Using sequence data, 1928 contributes to the fight against infections by identifying and characterizing pathogens to assist in tracking, controlling, and preventing outbreaks. Our innovation offers a solution to control the spread of infections and save the power of antibiotics, thereby improving world health and saving costs for healthcare systems.

CHANGING THE WORLD BY CHANGING THE WAY WE EAT In 2015, we had a serendipitous meeting of minds. Our purpose is to change the world by changing the way we eat. We empower people to cook delicious, healthy meals in minutes, improve their quality of life, and facilitate the transition toward food systems that truly nourish people and heal the planet. Plant-based with a pulse! We are pulse cooking experts obsessed with flavour and quality, and committed to creating the best tasting pulse-based products in the world. Pulses are the dried seeds of edible legumes. They are nature’s most sustainable protein source, and are packed with fibre, phytonutrients, polyphenols, vitamins and minerals. Consuming pulses regularly contribute to: • Improved digestive health • Lower risk of heart disease • Reduced risk of and improved management of type 2 diabetes • Improved weight control • Enhanced immune function • Promoting overall health and longevity. When they grow, the legume family pull nitrogen from the atmosphere and fix it into the soil thereby enriching it. Legumes are therefore an essential part of regenerative farming systems and future food security. As such, by eating pulses regularly we are effectively helping to change the world by changing the way we eat. Join the movement. Becoming a pulse lover had never been easier or more delicious!

Fairlo is on a mission to level the playing field and outsmart the predatory credit market by creating fair financial services from scratch. Since launch, our customers solve short- to medium term borrowing needs in real-time. With the aid of technology, weve created automated, easy-to-use services based on transparency and fairness. We pair our cutting-edge tech with unprecedented terms. Fair terms that continually beat traditional banks, popular credit cards and checkout solutions alike. Were backed by one of the Nordics most well-known incubators – Sting, Stockholm Innovation & Growth AB – as well as Swedish state-owned Saminvest and a multitude of experienced investors. Were an international company with roots in the Swedish capital of Stockholm. Follow us on LinkedIn to get the latest on investing rounds, hiring, tech development, press, and thought leadership.

Beactica Therapeutics is a specialist drug discovery and development company, committed to the fight against cancer. Beactica is advancing a proprietary pipeline of first-in-class therapeutics by applying its molecular interaction-based drug discovery engine synergistically across multiple small molecule modalities – including allosteric modulators, protein–protein interaction inhibitors and targeted protein degraders (PROTACs).

1928 Diagnostics offers a bioinformatics analytics platform for infection control. Using sequence data, 1928 contributes to the fight against infections by identifying and characterizing pathogens to assist in tracking, controlling, and preventing outbreaks. Our innovation offers a solution to control the spread of infections and save the power of antibiotics, thereby improving world health and saving costs for healthcare systems.

I gränslandet mellan life science, dataanalys och IT hjälper Reveal organisationer och företag att fatta datadrivna beslut. Genom att presentera statistik över läkemedelsanvändning, prisstrategier och följsamhet hjälper vi vårdgivare, läkemedelsföretag, myndigheter och apotek att effektivisera sina verksamheter och bli mer konkurrenskraftiga. Sedan starten 2012 har antalet kunder, tjänster och produkter stadigt växt. Vårt fokus ligger på ständig utveckling och vår ambition är att erbjuda marknadens bästa produkter och service. Detta för att även i framtiden erbjuda mervärde och nytänkande inom läkemedelsstatisik och närliggande områden.